HOLLY MCFADDEN: Open Payments
NPI 1003200452 · SELLERSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 32 payments from 22 companies in 2025. Trend: 2023 $643 · 2024 $1,112 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $96 |
| ABBVIE INC. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Incyte Corporation | 2 | $46 |
| Genentech USA, Inc. | 2 | $42 |
| Novocure Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $38 |
| Karyopharm Therapeutics Inc. | 1 | $35 |
| Janssen Biotech, Inc. | 1 | $31 |
Products named: KEYTRUDA, VENCLEXTA, Nubeqa, ENHERTU, Optune Lua (NovoTTF-200T), SARCLISA, XPOVIO, Fabhalta.
Industry payments across PA — which companies pay providers there.
